Skip to main content

Table 1 Characteristics of the studies included in the meta-analysis

From: The association of selenium exposure with the odds of metabolic syndrome: a dose-response meta-analysis

Study

Year

Country

Type of study

Cases with MetS

Total sample size

Mean age

Population

MetS definition

Selenium measurement

Gender (%males)

Sample type

Adjustment

Huang

2021

China

Cross-sectional

628

2109

60.18 ± 11.77

Community-based

IDF

ICP-MS

Both (42.3%)

Urine

Age, gender, and BMI

Feng

2020

China

Cohort

254

1970

41.8 ± 10.2

Community-based

Chinese criteria

ICP-MS

Male

Serum

Age, smoking, alcohol drinking, physical activity, education status, and family history

Arnaud

2010

France

Cross-sectional

293

1902

49.1 ± 7.5

Community-based, diabetic-free population

IDF

Atomic absorption spectrometry

Both (66%)

Serum

Age, group, social status, physical activity, energy intake, alcohol consumption, smoking and hormonal status

Lu

2019

Taiwan

Case-control

709

1165

64.9 ± 10.3

Hospital-based

NCEP-ATP III

ICP-MS

Both (36%)

Serum

Age, gender, current smoking status, current drinking status, physical activity, BMI, and HOMA-IR

Schneider-Matyka

2023

Poland

Case-control

72

390

52.59 ± 5.05

Community-based

IDF

Spectrofluorimetry

Female

Serum

NR

Fang

2018

China

Case-control

125

698

65.35 ± 7.86

Community-based

Chinese criteria

Atomic absorption spectrometry

Both (36%)

Serum

Smoking habit, alcohol consumption, physical activity and medication use at baseline

Guo

2019

China

Cross-sectional

80

145

39 ± 12

Hospital-based

NCEP-ATP III

ICP-MS

Male

Serum

Age

Deng

2023

China

Cross-sectional

278

1451

NR

Community-based

NR

NR

Male

Serum

NR

Jang

2018

Republic of Korea

Cross-sectional

40

500

≥ 35

Community-based

NCEP-ATP III

Neutron activation analysis

Both (NR)

Toenail

Age, sex, education level, smoking status, physical activity level, alcohol consumption status and total

energy intake, family history of diabetes, hypertension and cardiovascular disease

Ma

2020

China

Cross-sectional

526

3272

58.14 ± 10.49

Community-based

NCEP-ATP III

ICP-MS

Both (26.4%)

Urine

Age, BMI, gender, race, education, smoking status, drinking status, traffic time, passive smoke status, city, medications, diet frequency, and physical activity status

Zhou

2020

China

Case-control

1279

2558

55.56 ± 10.46

Community-based

The Joint Interim Statement

ICP-MS

Both (64%)

Serum

Sex, age, BMI, smoking, drinking, physical activity, and education level

Pang

2024

China

Cross-sectional

395

852

72.86 ± 5.87

Community-based

NR

ICP-MS

Both (36.7%)

Serum

Gender, waistline, eGFR, age, smoke, drink, serum creatinine, health satisfaction

Kelishadi

2014

Iran

Case-control

160

320

15.3 ± 2.6

Community-based

NCEP-ATP III

Atomic absorption spectrometry

Both (nr)

Serum

Age and sex

Lu

2016

Taiwan

Case-control

418

847

65.2 ± 9.6

Hospital-based, patients with diabetes mellitus

IDF

ICP-MS

Both (64%)

Serum

NR

Huang

2022

China

Cross-sectional

149

1277

62.51 ± 8.44

Hospital-based

Chinese criteria

ICP-MS

Both (44.3%)

Serum

Age, sex, smoking, drinking status and eGFR

Yuan

2015

China

Case-control

204

408

64.0 ± 6.4

Community-based

Chinese criteria

Atomic absorption spectrometry

Both (44.1%)

Serum

Gender and age

Guo

2023

China

Case-control

292

584

73.4 ± 5.74

Community-based

Chinese criteria

ICP-MS

Both (32.2%)

Serum

Age, sex, smoking status, drinking status.

Zhang

2020

China

Case-control

428

1033

60.1 ± 5.8

Community-based

IDF

ICP-MS

Both (49.2%)

Serum

Education level, smoking status, alcohol intake status, BMI, physical activity, family history of disease.

  1. NR: not reported, MetS: metabolic syndrome, BMI: body mass index, NCEP-ATP III: the National Cholesterol Education Program Expert Panel and Adult Treatment Panel III, IDF: International Diabetes Federation, ICP-MS: Inductively coupled plasma mass spectrometry, HOMA-IR: Homeostatic Model Assessment for Insulin Resistance, eGFR: estimate glomerular filtration rate